MRC-RT01_2A | R Documentation |
Kaplan-Meier digitized data from MRC-RT01, figure 2A (PMID 24581940). A reported sample size of 862 for a primary endpoint of bPFS/OS in prostate cancer.
`MRC-RT01_2A`
A data frame of 836 observations and 3 variables:
time | event time (in years) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (control, escalated) | |
Dearnaley DP, Jovic G, Syndikus I, et al. Escalated-dose versus control-dose conformal radiotherapy for prostate cancer: long-term results from the MRC RT01 randomised controlled trial. Lancet Oncol 2014; 15: 464–73.
summary(`MRC-RT01_2A`)
kmplot(`MRC-RT01_2A`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.